Ironwood pharmaceuticals news
WebGreat news for Ford and Canadian Automotive industry! ... Director at Ironwood Pharmaceuticals Greater Boston. Lara Lane Nursing Student seeking RN Position Tampa, … WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, CEO Thomas A. Mccourt sold 46,129 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, March …
Ironwood pharmaceuticals news
Did you know?
WebJan 9, 2024 · Ironwood Pharmaceuticals Provides Update on FY 2024 Financial Guidance and Announces FY 2024 Financial Guidance – sNDA submitted to U.S. FDA in December … WebApr 14, 2024 · Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23...
WebApr 14, 2024 · Ironwood Pharmaceuticals has a one year low of $9.73 and a one year high of $12.66. Ironwood Pharmaceuticals ( NASDAQ:IRWD – Get Rating) last announced its … WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC.
WebIronwood Pharmaceuticals 6 years 8 months Executive Clinical Sales Consultant Ironwood Pharmaceuticals Mar 2024 - Present 2 months. Detroit, Michigan, United States Senior … WebJan 29, 2024 · Astellas Pharma Inc. (TSE:4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in Japan as the first prescription treatment for adults …
WebApr 12, 2024 · Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)’s beta value is currently sitting at 0.95, while the Average True Range indicator is currently displaying 0.29. With analysts defining $9.00-$16.00 as the low and high price targets, we arrive at a consensus price target of $12.75 for the trailing 12-month period.
WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, COO Jason Rickard sold 16,746 shares of the stock in a transaction on Monday, February 27th. The shares were sold at an average price of $11.41, for a total ... read aloud option in wordWebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate the role of COO, and Rickard's ... how to stop in app purchasesWebApr 15, 2024 · As a group, sell-side analysts forecast that Ironwood Pharmaceuticals, Inc. will post 1.06 earnings per share for the current fiscal year. Insider Transactions at Ironwood Pharmaceuticals. In other news, CEO Thomas A. Mccourt sold 46,129 shares of the business’s stock in a transaction that occurred on Monday, March 27th. The stock was … how to stop imusic popping up on my iphoneWebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … read aloud one fish two fishWebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate … how to stop in cmdWebIronwood Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will participate in the following investor conferences: Cowen 43rd Annual Health Care Conference on Monday, March 6, 2024 at … read aloud pdf microsoft edge linuxWebIronwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidance. Markets Insider Automation 54d. Ironwood Pharmaceuticals A earnings ... how to stop in app purchases iphone